フィルターを表示する
リソースの種類
フィルターで絞り込む リソースの種類
Pathologies
フィルターで絞り込む Pathologies
Technologies
フィルターで絞り込む Technologies
Instruments
フィルターで絞り込む Instruments
19 検索結果
並び替え:

Timely Diagnosis of Myeloma in Populations with Comorbidities and Health Disparities: Testing Considerations

ウェビナー
9月. 05, 2024

Educational Webinar with Dr. Joseph Mikhael MD and Dr. Christopher Farnsworth, PhD

4月. 18, 2024 4月. 20, 2024

イベント
Torino, Italy

European Myeloma Network Meeting – EMN 2024

Sebia booth: #9

詳細はこちら

HYDRASYS 2 SCAN FOCUSING: Overview

ビデオ
2月. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

プレスリリース
12月. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

12月. 09, 2023 12月. 11, 2023

イベント
San Diego, CA

ASH 2023

Sebia booth: #2455

詳細はこちら

Challenges in Implementing Capillary Electrophoresis for Immunotyping

ウェビナー
3月. 29, 2023

Educational Webinar with Dr. Jack Maggiore from Loyola University Medical Center in Chicago, IL

Modern Approach to Screening for Monoclonal Gammopathies Using Digital Workflows

ウェビナー
2月. 23, 2023

Educational Webinar with Dr. Mark Zaydman from Washington University School of Medicine in St. Louis, MO